Ā | Total, Nā=ā5955 | T1, Nā=ā1985 | T2, Nā=ā1985 | T3, Nā=ā1985 | P value |
---|---|---|---|---|---|
SerumĀ free thiol (Ī¼mol/g) levels (adjusted for protein) | 5.05 (Ā±ā1.02) Ī¼mol/g | <ā4.65āĪ¼mol/g | 4.65ā5.46āĪ¼mol/g | >ā5.46āĪ¼mol/g | Ā |
Age (years) | 51.6 (43.3ā61.7) | 57.6 (47.8ā66.6) | 51.1 (43.4ā59.8) | 47.7 (41.1ā55.3) | <ā0.001 |
Female, n (%) | 3038 (51.0%) | 1084 (54.6%) | 1013 (51.0%) | 941 (47.4%) | <ā0.001 |
Blood pressure | |||||
āSBP (mmHg) | 126 (Ā±ā19) | 129 (Ā±ā20) | 125 (Ā±ā18) | 123 (Ā±ā17) | <ā0.001 |
āDBP (mmHg) | 73 (Ā±ā9) | 74 (Ā±ā9) | 73 (Ā±ā9) | 73 (Ā±ā9) | <ā0.001 |
āHeart rate (bpm) | 68 (Ā±ā10) | 69 (Ā±ā11) | 69 (Ā±ā10) | 68 (Ā±ā10) | 0.44 |
Obesity variables | |||||
āBMI (kg/m2) | 26.0 (23.6ā28.9) | 26.8 (24.3ā29.9) | 26.0 (23.6ā28.7) | 25.3 (23.0ā28.0) | <ā0.001 |
āWaist circumference (cm) | 91.0 (82.0ā100.0) | 94.0 (85.0ā102.0) | 91.0 (82.0ā100.0) | 89.0 (81.0ā98.0) | <ā0.001 |
Smoking, n (%) | Ā | Ā | Ā | Ā | <ā0.001 |
āNever, n (%) | 1757 (29.5%) | 583 (29.4%) | 578 (29.1%) | 596 (30.0%) | Ā |
āCurrent, n (%) | 1655 (27.8%) | 494 (24.9%) | 538 (27.1%) | 623 (31.4%) | Ā |
āFormer, n (%) | 2472 (41.5%) | 887 (44.7%) | 848 (42.7%) | 737 (37.1%) | Ā |
History of cardiovascular disease, n (%) | 217 (3.6%) | 100 (5.0%) | 69 (3.5%) | 48 (2.4%) | <ā0.001 |
Diabetes, n (%) | 144 (2.4%) | 76 (3.8%) | 34 (1.7%) | 34 (1.7%) | <ā0.001 |
Medication, n (%) | |||||
āAntihypertensive drugs, n (%) | 1037 (17.4%) | 481 (24.2%) | 307 (15.5%) | 249 (12.5%) | <ā0.001 |
āLipid-lowering drugs, n (%) | 371 (6.2%) | 155 (7.8%) | 126 (6.3%) | 90 (4.5%) | <ā0.001 |
āAntidiabetic drugs, n (%) | 78 (1.3%) | 40 (2.0%) | 19 (1.0%) | 19 (1.0%) | 0.006 |
Laboratory measurements | |||||
āTotal cholesterol (mmol/L) | 5.5 (Ā±ā1.0) | 5.5 (Ā±ā1.0) | 5.5 (Ā±ā1.0) | 5.4 (Ā±ā1.1) | <ā0.001 |
āHDL (mmol/L) | 1.2 (1.0ā1.5) | 1.2 (1.1ā1.5) | 1.2 (1.0ā1.4) | 1.2 (1.0ā1.4) | 0.68 |
āLDL (mmol/L) | 3.4 (2.7ā4.2) | 3.5 (2.8ā4.2) | 3.3 (2.7ā4.1) | 3.3 (2.6ā4.1) | 0.20 |
āTriglycerides (mmol/L) | 1.1 (0.8ā1.6) | 1.1 (0.8ā1.6) | 1.1 (0.8ā1.6) | 1.0 (0.8ā1.6) | 0.001 |
āhsCRP (mg/L) | 1.3 (0.6ā2.9) | 1.6 (0.8ā3.9) | 1.3 (0.6ā2.8) | 1.0 (0.5ā2.3) | <ā0.001 |
āFasting glucose (mmol/L) | 4.7 (4.4ā5.2) | 4.8 (4.5ā5.3) | 4.7 (4.4ā5.2) | 4.7 (4.4ā5.2) | <ā0.001 |
āeGFR (mL/min/1.73Ā m2) | 94.5 (82.2ā104.7) | 86.5 (74.7ā99.0) | 95.0 (83.9ā14.0) | 99.8 (90.1ā108.2) | <ā0.001 |
āAlbuminuria (mg/L) | 8.5 (6.0ā15.0) | 9.3 (6.2ā19.0) | 8.4 (6.0ā14.0) | 8.1 (5.95ā13.1) | <ā0.001 |
CV events, n (%) | 402 (6.8%) | 184 (9.3%) | 127 (6.4%) | 91 (4.6%) | <ā0.001 |
Mortality, n (%) | 316 (5.3%) | 171 (8.6%) | 85 (4.3%) | 60 (3.0%) | <ā0.001 |